AJU IB Investment Co., Ltd. Long-Term Concentrated

CIK: 0001710065 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 12, 2022

Total Value ($000): $64,761 (100.0% shares, 0.0% debt)

Holdings (7)

ACLX ARCELLX INC 29.9%

Value ($000) $19,360 Shares 1,380,890 Est. Cost $16.72 Unrealized 0.0%

KYMR KYMERA THERAPEUTICS INC 29.9%

Value ($000) $19,343 Shares 457,059 Est. Cost $48.78 Unrealized -13.4%

SEER SEER INC 19.2%

Value ($000) $12,442 Shares 816,375 Est. Cost $63.62 Unrealized -75.7%

— RALLYBIO CORP 8.1%

Value ($000) $5,268 Shares 754,678 Est. Cost $9.54 Unrealized —

XLO XILIO THERAPEUTICS INC 7.3%

Value ($000) $4,721 Shares 667,742 Est. Cost $17.03 Unrealized -33.7%

— RAPT THERAPEUTICS INC 3.4%

Value ($000) $2,188 Shares 99,503 Est. Cost $19.75 Unrealized —

— SUTRO BIOPHARMA INC 2.2%

Value ($000) $1,439 Shares 175,000 Est. Cost $21.71 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC	1,380,890	$19,360	29.9%	$16.72	0.0%	COMMON STOCK	03940C100
KYMR	KYMERA THERAPEUTICS INC	457,059	$19,343	29.9%	$48.78	-13.4%	COM	501575104
SEER	SEER INC	816,375	$12,442	19.2%	$63.62	-75.7%	COM CL A	81578P106
—	RALLYBIO CORP	754,678	$5,268	8.1%	$9.54	—	COM	75120L100
XLO	XILIO THERAPEUTICS INC	667,742	$4,721	7.3%	$17.03	-33.7%	COM	98422T100
—	RAPT THERAPEUTICS INC	99,503	$2,188	3.4%	$19.75	—	COM	75382E109
—	SUTRO BIOPHARMA INC	175,000	$1,439	2.2%	$21.71	—	COM	869367102